company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1419019.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4395266.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5814285.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5814285.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,27724.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,27724.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5786561.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5786561.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5786561.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5786561.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,88462128.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,88462128.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82700000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 15:19:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1220427.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2295362.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3515789.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3515789.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23171.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,110937.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,134108.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3381681.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3381681.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3381681.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3381681.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90102405.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90102405.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84500000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 17:01:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1897626.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1478126.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3375752.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3375752.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11877.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,24064.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-338715.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-326528.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3702280.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3702280.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3702280.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3702280.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46167416.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46167416.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46300000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 14:15:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1524402.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2354450.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3878852.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3878852.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20003.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-697660.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-677657.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4556509.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4556509.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4556509.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4556509.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45600000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45600000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46642901.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q2,2011-04-01,2011-06-30,2012-08-09 14:36:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1102844.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3882803.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4985647.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4985647.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4382796.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4402796.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-582851.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-582851.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-582851.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-582851.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58300000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58300000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47308946.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:13:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2220128.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5703621.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7923749.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7923749.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,123.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25933.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2272579.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2298389.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5625360.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5625360.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5625360.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5625360.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48200000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48200000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47598240.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1732000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5338000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7070000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7070000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,39000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,47000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7023000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7023000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7023000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7023000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54298079.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:16:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1919000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7626000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9545000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9545000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,48000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1317000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1269000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10814000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,256000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10558000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10558000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10558000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62100000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,62100000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,60416068.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 07:02:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1843000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8246000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10089000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10089000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,63000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,140000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,203000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9886000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9886000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9886000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9886000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65900000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65900000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65806178.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 16:46:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2447000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9084000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11531000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11531000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,68000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-258000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-190000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11721000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-256000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11977000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11977000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11977000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61600000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61600000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61702277.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3278000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14344000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17622000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17622000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1093000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1075000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18697000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18697000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18697000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18697000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71900000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71900000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72789006.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 17:29:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2803000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9055000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11858000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11858000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1803000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1819000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10039000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10039000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10039000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10039000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91300000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,91300000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,87482939.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:08:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2692000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10782000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13474000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13474000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-77000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-63000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13537000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13537000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13537000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13537000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90200000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90200000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,90182115.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:01:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2908000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16449000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19357000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19357000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-10000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-484000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-494000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19851000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19851000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19851000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19851000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,85100000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,85100000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85220458.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3178000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13299000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16477000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16477000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,223000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,252000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16225000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16225000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16225000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16225000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90100000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90100000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,92056124.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:06:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2279000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24479000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26758000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26758000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,839000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,838000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25920000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25920000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25920000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25920000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,92600000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,92600000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94069703.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:11:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2506000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20946000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23452000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23452000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-19000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,425000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,444000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23008000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23008000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23008000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23008000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,95900000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,95900000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94738048.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 06:48:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3041000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24550000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27591000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27591000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-2493000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-453000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2964000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30555000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30555000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30555000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30555000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,93800000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,93800000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94276178.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4606000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18198000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22804000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22804000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4317000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-268000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4585000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27389000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27389000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27389000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27389000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97800000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97800000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,96683525.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:10:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7394000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19525000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26919000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26919000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5207000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1542000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6749000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33668000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33668000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33668000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33668000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,100343637.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:13:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2728000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20424000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23152000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23152000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4291000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1446000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2845000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25997000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25997000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25997000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25997000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,113000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,113000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,111328339.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7066000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19881000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26947000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26947000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3469000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-30000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3499000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30446000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30446000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30446000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30446000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105900000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,105900000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105570960.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6375000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21175000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27550000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27550000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,32651000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,260000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-32391000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-59941000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59941000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59941000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59941000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,117500000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,117500000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,117626669.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:51:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10249000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26611000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36860000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-36860000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1673000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1696000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38556000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38556000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38556000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38556000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,167600000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,167600000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,168127144.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:56:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13872000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24610000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38482000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38482000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1674000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-87000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1761000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40243000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40243000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40243000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-40243000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,182900000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,182900000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,179786580.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 17:07:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27734000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14660000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42394000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-42394000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17550000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,77000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17473000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-59867000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59867000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59867000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59867000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,164100000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,164100000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,164437548.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,98000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,98000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1636000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1636000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-1538000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42788000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18401000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61189000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-62727000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1999000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,122000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1877000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-64604000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64604000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-64604000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-64604000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,215300000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215300000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,215484670.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:32:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2314000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2314000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1643000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1643000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,671000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52185000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22069000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74254000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-73583000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,345000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,39000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-306000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-73889000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-73889000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-73889000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-73889000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223900000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,223900000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,224948622.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 13:12:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5008000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5008000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1722000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1722000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3286000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45110000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5876000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50986000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47700000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1226000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,55000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1171000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-48871000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48871000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48871000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-48871000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,222100000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,222100000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,224954941.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q3,2017-07-01,2017-09-30,2018-11-09 09:06:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9400000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9400000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3810000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3810000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5590000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41779000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2000000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43779000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38189000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2909000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4124000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1215000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36974000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36974000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36974000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36974000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224300000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,224300000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,225439121.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8586000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8586000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3704000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3704000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4882000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,40145000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3392000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43537000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38655000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3123000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5674000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2551000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36104000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36104000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36104000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36104000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,240700000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,240700000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,246664067.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q1,2018-01-01,2018-03-31,2018-05-10 16:32:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12254000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12254000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3885000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3885000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8369000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34615000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2844000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37459000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29090000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3205000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2604000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-601000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29691000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29691000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29691000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29691000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,247400000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,247400000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,246990080.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q2,2018-04-01,2018-06-30,2018-08-08 13:12:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11105000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11105000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3922000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3922000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7183000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33887000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2904000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36791000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29608000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3369000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-433000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3802000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33410000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1133000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34543000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34543000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34543000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,246700000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,246700000.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,247994922.0
Synergy Pharmaceuticals Inc,SGYP,549300ITFHW1YXFTGH91,0001347613,2018.0,Q3,2018-07-01,2018-09-30,2018-11-09 09:06:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
